Guangzhou Baiyunshan Pharmaceutical saw the highest growth of 116% in patent filings and 97% in grants in January in Q1 2024. Compared to Q4 2023, Q1 2024 saw an increase in patent filings by 116% and grants by 97%. GlobalData’s DataBook provides a comprehensive analysis of Guangzhou Baiyunshan Pharmaceutical’s patent filings and grants. Buy the databook here.

Guangzhou Baiyunshan Pharmaceutical has been focused on protecting inventions in China(CN) with 91 publications in Q1 2024

The China(CN) Patent Office dominates the patent filings and grants with nearly 80% filings and 72% grants. The China(CN), World Intellectual Property Organization(WIPO), European Patent Office(EPO), and United States(US) patent Office are among the top ten patent offices where Guangzhou Baiyunshan Pharmaceutical is filings its patents. Among the top granted patent authorities, Guangzhou Baiyunshan Pharmaceutical has 72% of its grants in China(CN), 22% in United States(US) and 6% in Australia(AU).

F. Hoffmann-La Roche and Bristol-Myers Squibb could be the strongest competitors for Guangzhou Baiyunshan Pharmaceutical

Patents related to climate change and emissions reduction lead Guangzhou Baiyunshan Pharmaceutical's portfolio

Guangzhou Baiyunshan Pharmaceutical has the highest number of patents in climate change followed by, emissions reduction and edge computing. For climate change, nearly 11% of patents were filed and 38% of patents were granted in Q1 2024.

Conferencing & telepresence related patents lead Guangzhou Baiyunshan Pharmaceutical portfolio followed by pharmaceutical ingredients, and hospital supplies

Guangzhou Baiyunshan Pharmaceutical has highest number of patents in conferencing & telepresence followed by pharmaceutical ingredients, hospital supplies, machine learning, and integrated circuits.

For comprehensive analysis of Guangzhou Baiyunshan Pharmaceutical's filings and grants, buy the databook here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.

Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.